{"id":"W2032051122","doi":"10.1186/1471-2407-9-34","title":"Metastatic renal cell cancer treatments: An indirect comparison meta-analysis","year":2009,"lang":"en","type":"review","venue":"BMC Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; McMaster University; St. Joseph’s Healthcare Hamilton; Simon Fraser University","funders":"Pfizer","keywords":"Sorafenib; Medicine; Bevacizumab; Sunitinib; Temsirolimus; Internal medicine; Oncology; Meta-analysis; Progression-free survival; Placebo; Renal cell carcinoma; Overall survival; Pathology; Hepatocellular carcinoma; Chemotherapy; Discovery and development of mTOR inhibitors; PI3K/AKT/mTOR pathway","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03123841,0.004434845,0.01593072,0.004735733,0.0005911937,0.002818526,0.003265585,0.002944941,0.006764716],"category_scores_gemma":[0.06021656,0.002150218,0.05223586,0.004403363,0.0006989198,0.002161861,0.002160317,0.004250218,0.0005138049],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002434354,"about_ca_system_score_gemma":0.002055343,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.008544588,"about_ca_topic_score_gemma":0.00929782,"domain_scores_codex":[0.9494118,0.04319864,0.00279891,0.002373393,0.001617544,0.0005996204],"domain_scores_gemma":[0.9589865,0.03571785,0.002447743,0.001377652,0.001119939,0.0003502468],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.01240544,0.00005776465,0.002977631,0.03603778,0.941297,0.0001097057,0.00004844983,0.002193237,0.0001145423,0.0003082384,0.0007000546,0.003750283],"study_design_scores_gemma":[0.008381268,0.000654251,0.002236273,0.002322473,0.982027,0.00009146445,0.00002853933,0.00202158,0.0001145114,0.0008647182,0.001226329,0.00003164024],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.06099848,0.911202,0.01365608,0.001636759,0.001972809,0.002495327,0.005032169,0.0003455487,0.002660846],"genre_scores_gemma":[0.81141,0.1514623,0.02088407,0.002279931,0.0008888444,0.007265389,0.00342019,0.0001743671,0.002214978],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.03123841,"threshold_uncertainty_score":0.1652064,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.357591453005252,"score_gpt":0.4566730649210486,"score_spread":0.09908161191579667,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}